Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gian Marco Berti

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|April 15, 2024
Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insightsIrene Capelli, Sarah Lerario, Francesca Ciurli, et al.
BMC Nephrology|December 21, 2023
Rituximab as possible therapy in TNF inhibitor-induced IgA vasculitis with severe renal involvementAgnieszka Przygocka, Gian Marco Berti, Anita Campus, et al.
Nephron|April 6, 2025
The Fabry Nephropathy in Patients with N215S VariantRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
Mayo Clinic Proceedings|March 6, 2026
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Orphanet Journal of Rare Diseases|September 2, 2025
Functional and histopathologic correlation in the fabry nephropathy with N215S genotypeRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
The Lancet. Infectious Diseases|March 13, 2025
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literatureGian Marco Berti, Elisabetta Manaresi, Gisella Vischini, et al.
Biomedicines|April 29, 2025
The Role of Kidney Biopsy in Fabry DiseaseIrene Capelli, Laura Martano, Gian Marco Berti, et al.
Kidney International Reports|August 15, 2025
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With RituximabMaria J Vargas-Brochero, Elisabeth Lafaut, Yeshwanter Radhakrishnan, et al.
BMC Nephrology|February 13, 2025
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry diseaseGian Marco Berti, Valeria Aiello, Gisella Vischini, et al.
Journal of Nephrology|February 10, 2025
The need for clinical, genetic and radiological characterization of atypical polycystic kidney diseaseMatteo Righini, Cristiana Corsi, Nicola Sciascia, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|April 15, 2024
Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insightsIrene Capelli, Sarah Lerario, Francesca Ciurli, et al.
BMC Nephrology|December 21, 2023
Rituximab as possible therapy in TNF inhibitor-induced IgA vasculitis with severe renal involvementAgnieszka Przygocka, Gian Marco Berti, Anita Campus, et al.
Nephron|April 6, 2025
The Fabry Nephropathy in Patients with N215S VariantRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
Mayo Clinic Proceedings|March 6, 2026
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous NephropathyIlario Russo, Maria J Vargas-Brochero, Anila Cara, et al.
Orphanet Journal of Rare Diseases|September 2, 2025
Functional and histopathologic correlation in the fabry nephropathy with N215S genotypeRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
The Lancet. Infectious Diseases|March 13, 2025
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literatureGian Marco Berti, Elisabetta Manaresi, Gisella Vischini, et al.
Biomedicines|April 29, 2025
The Role of Kidney Biopsy in Fabry DiseaseIrene Capelli, Laura Martano, Gian Marco Berti, et al.
Kidney International Reports|August 15, 2025
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With RituximabMaria J Vargas-Brochero, Elisabeth Lafaut, Yeshwanter Radhakrishnan, et al.
BMC Nephrology|February 13, 2025
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry diseaseGian Marco Berti, Valeria Aiello, Gisella Vischini, et al.
Journal of Nephrology|February 10, 2025
The need for clinical, genetic and radiological characterization of atypical polycystic kidney diseaseMatteo Righini, Cristiana Corsi, Nicola Sciascia, et al.
Pageof 2